Cargando…

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines

Resistance to protein tyrosine kinase inhibitors (TKIs) presents a significant challenge in therapeutic target development for cancers such as triple-negative breast cancer (TNBC), where conventional therapies are ineffective at combatting systemic disease. Due to increased expression, the receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lefebvre, Cory, Pellizzari, Sierra, Bhat, Vasudeva, Jurcic, Kristina, Litchfield, David W., Allan, Alison L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525382/
https://www.ncbi.nlm.nih.gov/pubmed/37760847
http://dx.doi.org/10.3390/biomedicines11092406